Led by the Francis Crick Institute in the UK, the team brings together clinicians, scientists and patient advocates, with researchers spanning eight institutions across four countries. The award is funded jointly by Cancer Research UK and the National Cancer Institute in the US, two of the world’s largest cancer research funders, through the global Cancer Grand Challenges initiative. It marks the first time this prestigious international award has been granted to a Portuguese institution.

Host

Klaas Vangisbergen, PhD, Tissue Immunity Lab

Venue

Seminar Room

Brand rankings and reputation studies are published every year, nationally and internationally, often attracting attention for their league tables and headline positions. While such studies are inevitably shaped by methodological choices, sampling criteria, and contextual factors, they can nonetheless offer a useful lens for understanding how organisations are perceived within a shared ecosystem.

Healthcare is entering a decisive decade.

Artificial Intelligence (AI) is no longer a promise on the horizon – it is already transforming diagnostics, treatment, research, education and health systems worldwide. The real challenge we now face is not whether AI will change healthcare, but how we design that transformation responsibly, sustainably and at scale.

Date and Time

27 March 2026, 2:30pm – 6:30pm

Location

Auditorium, Champalimaud Foundation, Lisbon

About

PATEO is a Science4Policy project that translates scientific evidence on the prevention of dementia and age-related functional decline into concrete, actionable solutions to support healthier aging, greater autonomy and improved quality of life.

Fifty years ago, Total Mesorectal Excision (TME) transformed rectal cancer surgery, improving local control, survival and quality of life worldwide.

On 22–23 May 2026, the International Rectal Cancer Meeting - “50 Years of Total Mesorectal Excision: Celebrating the Legacy of Bill Heald” will bring leading experts to the Champalimaud Centre for the Unknown in Lisbon to mark this milestone and explore what lies ahead.
 

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab

Venue

Seminar Room

[THIS CALL IS NOW CLOSED]

Currently, the reference standard treatment for locally advanced rectal cancer, meaning tumours that have grown deeper into the layers of the rectal wall and/or involved nearby lymph nodes, but have not yet spread to the rest of the body – is to submit patients to chemotherapy and radiotherapy before surgery. This “total neoadjuvant therapy” reduces the risk of the cancer coming back in the rectum and can lower the risk of metastases, but has a cost for the patients because of the detrimental effects of radiation. 

Professor Parreira, Clinical Director of the Champalimaud Clinical Centre since its founding, was distinguished by the President of the Portuguese Republic, Marcelo Rebelo de Sousa, with the rank of Grand Officer of the Order of Public Instruction. The ceremony took place in Palácio de Belém on the 14th of january, 2026.